Abstract
Biosensors are of great interest for their ability to monitor clinically important analytes such as blood gases, electrolytes, and metabolites. A classic example is to monitor the dynamics of blood-glucose levels for treating diabetes. However, the current practice, based on a three decade old technology, requires a drop of blood on a test strip, which is in dire need of replacement. The increasing demands and interests in developing implantable glucose sensors for treating diabetes has led to notable progress in this area, and various electrochemical sensors have been developed for intravascular and subcutaneous applications. However, implantations are plagued by biofouling, tissue destruction and infection around the implanted sensors and the response signals must be interpreted in terms of blood or plasma concentrations for clinical utility, rather than tissue fluid levels. This review focuses on the potentials and pitfalls of implantable electrochemical sensors and presents our opinions about future possibilities of such implantable devices with respect to biocompatibility issues, long-term calibration, and other aging effects on the sensors.
Keywords: Implantable electrochemical sensor, Glucose, Blood gases, Electrolyte, Biomaterials, In vivo monitoring, Biocompatibility, Device, Membrane
Current Medicinal Chemistry
Title: Implantable Electrochemical Sensors for Biomedical and Clinical Applications: Progress, Problems, and Future Possibilities.
Volume: 14 Issue: 8
Author(s): Chang Ming Li, Hua Dong, Xiaodong Cao, John H. T. Luong and Xueji Zhang
Affiliation:
Keywords: Implantable electrochemical sensor, Glucose, Blood gases, Electrolyte, Biomaterials, In vivo monitoring, Biocompatibility, Device, Membrane
Abstract: Biosensors are of great interest for their ability to monitor clinically important analytes such as blood gases, electrolytes, and metabolites. A classic example is to monitor the dynamics of blood-glucose levels for treating diabetes. However, the current practice, based on a three decade old technology, requires a drop of blood on a test strip, which is in dire need of replacement. The increasing demands and interests in developing implantable glucose sensors for treating diabetes has led to notable progress in this area, and various electrochemical sensors have been developed for intravascular and subcutaneous applications. However, implantations are plagued by biofouling, tissue destruction and infection around the implanted sensors and the response signals must be interpreted in terms of blood or plasma concentrations for clinical utility, rather than tissue fluid levels. This review focuses on the potentials and pitfalls of implantable electrochemical sensors and presents our opinions about future possibilities of such implantable devices with respect to biocompatibility issues, long-term calibration, and other aging effects on the sensors.
Export Options
About this article
Cite this article as:
Ming Li Chang, Dong Hua, Cao Xiaodong, T. Luong H. John and Zhang Xueji, Implantable Electrochemical Sensors for Biomedical and Clinical Applications: Progress, Problems, and Future Possibilities., Current Medicinal Chemistry 2007; 14 (8) . https://dx.doi.org/10.2174/092986707780362970
DOI https://dx.doi.org/10.2174/092986707780362970 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Poly(Ethylene Glycol)-block-Poly(ε-Caprolactone) Nanomicelles for the Solubilization and Enhancement of Antifungal Activity of Sertaconazole
Current Drug Delivery Obesity and Body Composition in Man and Woman: Associated Diseases and the New Role of Gut Microbiota
Current Medicinal Chemistry Current Place of Beta-Blockers in the Treatment of Hypertension
Current Vascular Pharmacology Targeting Platinum Resistant Disease in Ovarian Cancer
Current Medicinal Chemistry Effect of Iontophoresis and Permeation Enhancers on the Permeation of an Acyclovir Gel
Current Drug Delivery Stage-Dependent Agreement between Cerebrospinal Fluid Proteins and FDG-PET Findings in Alzheimer's Disease
Current Alzheimer Research ACE Inhibitor-Angiotensin Receptor Blocker Combinations: A Clinicians Perspective
Mini-Reviews in Medicinal Chemistry In vitro characterisation of Span™ 65 niosomal formulations containing proteins
Current Drug Delivery Editorial:
Endocrine, Metabolic & Immune Disorders - Drug Targets Nutritional Interventions and Considerations for the Development of Low Calorie or Sugar Free Foods
Current Diabetes Reviews Subject Index To Volume 2
Current Hypertension Reviews Design of Experiment, Preparation, and in vitro Biological Assessment of Human Amniotic Membrane Extract Loaded Nanoparticles
Current Pharmaceutical Biotechnology Free Radical Scanvenging and Antioxidant Effects of Some Anthraquinone Derivatives
Medicinal Chemistry Leptin G-2548A and Leptin Receptor Q223R Gene Polymorphisms are Differently Associated with Oxidative Process in Mexican Mestizo and Indigenous with Obesity
Endocrine, Metabolic & Immune Disorders - Drug Targets Inflammatory Cytokines in Acute Ischemic Stroke
Current Pharmaceutical Design PI-3-Kinase Inhibitors in Colorectal Cancer
Current Cancer Drug Targets Pharmacological Effects of Secondary Bile Acid Microparticles in Diabetic Murine Model
Current Diabetes Reviews TRPV1: On the Road to Pain Relief
Current Molecular Pharmacology Novel Therapies Against Aggressive and Recurrent Epithelial Cancers by Molecular Targeting Tumor- and Metastasis-Initiating Cells and Their Progenies
Anti-Cancer Agents in Medicinal Chemistry Osteoporotic Fracture Healing: Potential Use of Medicinal Plants from the Tropics
Current Drug Targets